C12N 2740/15011
Lentivirus, not hiv
Official title: Lentivirus, not HIV, e.g. FIV, SIV
C12N2740/15011 (Lentivirus, not hiv) appears on 1,379 US grants and 2,858 published applications in this corpus.
Search patents in C12N- Granted patents
- 1,379
- Published applications
- 2,858
- Assignees
- 1,219
- Inventors
- 5,721
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 0 | 0 |
| 1980 | 0 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 4 | 0 |
| 1994 | 6 | 0 |
| 1995 | 8 | 0 |
| 1996 | 17 | 0 |
| 1997 | 21 | 0 |
| 1998 | 38 | 0 |
| 1999 | 27 | 0 |
| 2000 | 33 | 0 |
| 2001 | 32 | 9 |
| 2002 | 21 | 23 |
| 2003 | 26 | 74 |
| 2004 | 19 | 47 |
| 2005 | 12 | 55 |
| 2006 | 31 | 58 |
| 2007 | 22 | 39 |
| 2008 | 18 | 41 |
| 2009 | 26 | 48 |
| 2010 | 27 | 64 |
| 2011 | 24 | 64 |
| 2012 | 32 | 44 |
| 2013 | 23 | 47 |
| 2014 | 46 | 64 |
| 2015 | 49 | 85 |
| 2016 | 57 | 99 |
| 2017 | 43 | 102 |
| 2018 | 64 | 114 |
| 2019 | 70 | 136 |
| 2020 | 81 | 144 |
| 2021 | 60 | 157 |
| 2022 | 80 | 223 |
| 2023 | 87 | 211 |
| 2024 | 86 | 341 |
| 2025 | 97 | 321 |
| 2026 | 86 | 248 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C12N 2740/15041Use of virus, viral particle or viral elements as a vectorIndexing code841
- C12N 2740/15022New viral proteins or individual genes, new structural or functional aspects ofIndexing code391
- C12N 2740/15034Use of virus or viral component as vaccineIndexing code217
- C12N 2740/15051Methods of production or purification of viral materialIndexing code122
- C12N 2740/15071Demonstrated in vivo effectIndexing code56
- C12N 2740/15021Viruses as suchIndexing code51
- C12N 2740/15023Virus like particles [vlp]Indexing code39
- C12N 2740/15032Use of virus as therapeutic agent, other than vaccineIndexing code22
All 12 subgroupsShow fewer
Recent patents
- BCMA chimeric antigen receptors6 Oct 2026US 12,752,006 B2Regeneron Pharmaceuticals, Inc.
- Polypeptide exhibiting fluorescent properties and use for same6 Oct 2026US 12,753,213 B2Riken
- Composition for inducing direct cross differentiation of somatic cell into motor neuron, and method for using same6 Oct 2026US 12,753,385 B2Unist (Ulsan National Institute of Science and Technology)
- Immortalized keratinocytes, lentivirus for keratinocyte immortalization, and methods of use6 Oct 2026US 12,753,388 B2Regents of the University of Minnesota
- Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof29 Sep 2026US 12,747,279 B2Abelzeta Inc.
- Materials and methods for increasing immune responses within a mammal8 Oct 2026US 2026/0306668 A1Mayo Foundation for Medical Education and Research
- Hybrid transient transfection using transposase for high yield product production8 Oct 2026US 2026/0308275 A1Lonza Biologics PLC
- Genetically engineered cd4 t-cells for in situ synthesis of proteins8 Oct 2026US 2026/0308515 A1SRI International
- Methods of enhancing or modifying nk cells8 Oct 2026US 2026/0308525 A1Zelluna Immunotherapy AS
- Anti-cancer treatments and methods of use thereof8 Oct 2026US 2026/0308535 A1
Most cited
By later US patents
- Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains568US 8,993,233 B2Massachusetts Institute of Technology · 2015
- Engineering and optimization of systems, methods and compositions for sequence manipulation with functional domains475US 8,999,641 B2Maassachusetts Institute of Technology · 2015
- Methods for treatment of cancer368US 8,906,682 B2The Trustees of the University of Pennsylvania · 2014
- Compositions for treatment of cancer277US 8,911,993 B2The Trustees of the University of Pennsylvania · 2014
- Composition for introducing nucleic acid complexes into higher eucaryotic cells257US 5,547,932 ABoehringer Ingelheim International GmbH · 1996